Register Now

LAA Occlusion Devices: Iterating, Innovating, and Improving

September 19, 2026 | 09:40 AM (EDT) - 10:25 AM (EDT)

Share This event

Speakers
Christopher Ellis
Director LAA (Left Atrial Appendage) Program | Director AF Center
Vanderbilt University Medical Center
James Freeman
Professor of Medicine
Yale University School of Medicine
Bradley Knight
Director of Cardiac Electrophysiology | Director of the Heart Rhythm Center
Northwestern Medicine | Bluhm Cardiovascular Institute (BCVI)
Venkatakrishna Tholakanahalli
Professor of Medicine | Chief-Cardiac Electrophysiology
University of Minnesota | Minneapolis VA Health Care System

LAA Occlusion Devices: Iterating, Innovating, and Improving

Main Stage 2
September 19, 2026 | 09:40 AM (EDT) - 10:25 AM (EDT)

The first transvenous left atrial appendage occlusion device was approved by the FDA in 2015. There has been a lot of progress and change in the field in the subsequent decade. This session will chronicle the evolution of LAAO devices and the key opportunities for improvement and innovation moving forward.